SG80390G - Pharmaceutical composition comprising medroxyprogesterone acetate - Google Patents
Pharmaceutical composition comprising medroxyprogesterone acetateInfo
- Publication number
- SG80390G SG80390G SG803/90A SG80390A SG80390G SG 80390 G SG80390 G SG 80390G SG 803/90 A SG803/90 A SG 803/90A SG 80390 A SG80390 A SG 80390A SG 80390 G SG80390 G SG 80390G
- Authority
- SG
- Singapore
- Prior art keywords
- pharmaceutical composition
- medroxyprogesterone acetate
- medroxyprogesterone
- acetate
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB848403360A GB8403360D0 (en) | 1984-02-08 | 1984-02-08 | Pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG80390G true SG80390G (en) | 1990-11-23 |
Family
ID=10556300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG803/90A SG80390G (en) | 1984-02-08 | 1990-10-03 | Pharmaceutical composition comprising medroxyprogesterone acetate |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US4632828A (xx) |
| JP (1) | JPS60181017A (xx) |
| KR (1) | KR930009897B1 (xx) |
| AT (1) | AT388869B (xx) |
| AU (1) | AU577351B2 (xx) |
| BE (1) | BE901664A (xx) |
| BG (1) | BG60524B2 (xx) |
| CA (1) | CA1240928A (xx) |
| CH (1) | CH664693A5 (xx) |
| CZ (1) | CZ277728B6 (xx) |
| DE (1) | DE3503679A1 (xx) |
| DK (1) | DK164149C (xx) |
| ES (3) | ES8607984A1 (xx) |
| FI (1) | FI84230C (xx) |
| FR (1) | FR2559065B1 (xx) |
| GB (2) | GB8403360D0 (xx) |
| GR (1) | GR850312B (xx) |
| HK (1) | HK94290A (xx) |
| HU (1) | HU194050B (xx) |
| IE (1) | IE58230B1 (xx) |
| IL (1) | IL74241A (xx) |
| IT (1) | IT1209615B (xx) |
| NL (1) | NL192780C (xx) |
| NO (1) | NO170568C (xx) |
| NZ (1) | NZ211058A (xx) |
| PT (1) | PT79933B (xx) |
| SE (2) | SE8500553L (xx) |
| SG (1) | SG80390G (xx) |
| SK (1) | SK278084B6 (xx) |
| SU (1) | SU1605926A3 (xx) |
| UA (1) | UA6028A1 (xx) |
| ZA (1) | ZA85943B (xx) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1987005804A1 (en) * | 1986-04-01 | 1987-10-08 | The Upjohn Company | Methylprednisolone/sodium carboxymethyl starch tablet composition |
| US5019562A (en) * | 1988-01-19 | 1991-05-28 | The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation | Growth inhibiting agent and the use thereof |
| GB8806367D0 (en) * | 1988-03-17 | 1988-04-13 | Erba Carlo Spa | Siloxane matrices with internal non-uniform drug distribution |
| IE60458B1 (en) * | 1989-10-26 | 1994-07-13 | Elan Corp Plc | Enhanced bioavailability adsorbates |
| HU222501B1 (hu) * | 1991-06-28 | 2003-07-28 | Endorecherche Inc. | MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására |
| US5547948A (en) * | 1995-01-17 | 1996-08-20 | American Home Products Corporation | Controlled release of steroids from sugar coatings |
| US5759577A (en) * | 1995-01-17 | 1998-06-02 | American Home Products Corporation | Controlled release of steroids from sugar coatings |
| UA65607C2 (uk) | 1998-03-04 | 2004-04-15 | Орто-Макнейл Фармацевтикал, Інк. | Фармацевтична композиція (варіанти) та спосіб її приготування |
| DE19847252B4 (de) * | 1998-10-02 | 2004-02-12 | Jenapharm Gmbh & Co. Kg | Bukkal applizierbare bioadhäsive Systeme mit zeitlich gesteuerter Wirkstofffreisetzung enthaltend Testosteronester und fakultativ zusätzlich Testosteron |
| WO2000050041A1 (en) * | 1999-02-24 | 2000-08-31 | Akzo Nobel N.V. | Pharmaceutical compositions containing a crystalline form of the progestagen-(17alpha)-17-hydroxy-11-methylene-19-nor-pregna-4,15-dien-20-yn-3-one (org 30659) and lactose |
| US20020132839A1 (en) * | 2000-06-22 | 2002-09-19 | Ganter Sabina Maria | Tablet formulations comprising valsartan |
| AUPS244002A0 (en) * | 2002-05-20 | 2002-06-13 | John Kohnke Products Pty Ltd | Agent delivery system |
| DE10247037A1 (de) * | 2002-10-09 | 2004-04-22 | Abbott Gmbh & Co. Kg | Herstellung von festen Dosierungsformen unter Verwendung eines vernetzten nichtthermoplastischen Trägers |
| JP2005094910A (ja) * | 2003-09-17 | 2005-04-07 | Aruze Corp | モータ停止制御装置 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3545439A (en) * | 1968-01-04 | 1970-12-08 | Upjohn Co | Medicated devices and methods |
| AU454482B2 (en) * | 1970-11-05 | 1974-10-15 | Alza Corporation | Drug-delivery system |
| DE2200778B2 (de) * | 1971-01-13 | 1974-04-18 | Sandoz Ag, Basel (Schweiz) | Verwendung von hochmolekularem, unlöslichem, quervernetztem Polyvinylpyrrolidon als Sprengmittel in festen Arzneiformen |
| US4038389A (en) * | 1975-05-07 | 1977-07-26 | The Upjohn Company | Medroxyprogesterone acetate compositions |
| DE2634004B2 (de) * | 1976-07-29 | 1978-08-10 | Bernhard Dr. 8000 Muenchen Lippold | Verfahren zur Beschleunigung der Auflösung und Verbesserung der Löslichkeit von schlechtlöslichen zur peroralen Verabreichung bestimmten Arzneistoffen |
| CA1098443A (en) * | 1977-05-20 | 1981-03-31 | Namassivaya Doddi | Absorbable p-dioxanone polymer-drug compositions |
| SE431821B (sv) * | 1979-01-29 | 1984-03-05 | Perstorp Ab | Lagringsstabilt, prostaglandininnehallande medicinskt preparat |
| GB2042888B (en) * | 1979-03-05 | 1983-09-28 | Teijin Ltd | Preparation for administration to the mucosa of the oral or nasal cavity |
| GB2067900B (en) * | 1980-01-25 | 1983-06-22 | Ddsa Pharmaceuticals Ltd | Medicinal tablets |
| DE3006635A1 (de) * | 1980-02-22 | 1981-08-27 | Basf Ag, 6700 Ludwigshafen | Verwendung von mikronisiertem vernetztem, unloeslichem polyvinylpyrrolidon zur stabilisierung von suspensionen |
| DE3045135A1 (de) * | 1980-11-29 | 1982-06-09 | Sandoz-Patent-GmbH, 7850 Lörrach | Pharmazeutische kompositionen enthaltende bioabbaubare polymere |
| IL61721A (en) * | 1980-12-16 | 1984-03-30 | Blank Izhak | Nitroglycerin preparations |
| DE3125178A1 (de) * | 1981-06-26 | 1983-01-13 | Gödecke AG, 1000 Berlin | Verfahren zur zeitlichen steuerung der freisetzung von wirkstoffen aus wirkstoffzubereitungen, insbesondere arzneimittelzubereitungen |
| DE3270785D1 (en) * | 1981-10-29 | 1986-05-28 | Bayer Ag | Process for preparing solid fast-releasing drug formulations of dihydropyridines |
| DE3205399A1 (de) * | 1982-02-16 | 1983-08-25 | Bayer Ag, 5090 Leverkusen | Feste, schnellfreisetzende arzneizubereitungen mit dihydropyridinen und verfahren zu ihrer herstellung |
| EP0084190A3 (en) * | 1981-12-08 | 1984-11-28 | Fisons Plc | Medicinal composition, package and method of making the composition |
| GB2138286B (en) * | 1983-04-19 | 1986-10-08 | Dr Christopher Harry Mortimer | Pharmaceutical composition for the treatment of hair loss |
-
1984
- 1984-02-08 GB GB848403360A patent/GB8403360D0/en active Pending
-
1985
- 1985-01-25 ES ES539874A patent/ES8607984A1/es not_active Expired
- 1985-02-04 CH CH494/85A patent/CH664693A5/de not_active IP Right Cessation
- 1985-02-04 DE DE19853503679 patent/DE3503679A1/de active Granted
- 1985-02-04 AT AT0031685A patent/AT388869B/de not_active IP Right Cessation
- 1985-02-04 IE IE26185A patent/IE58230B1/en not_active IP Right Cessation
- 1985-02-04 GR GR850312A patent/GR850312B/el not_active IP Right Cessation
- 1985-02-04 FI FI850455A patent/FI84230C/fi not_active IP Right Cessation
- 1985-02-04 IL IL74241A patent/IL74241A/xx not_active IP Right Cessation
- 1985-02-05 CZ CS85784A patent/CZ277728B6/cs not_active IP Right Cessation
- 1985-02-05 NZ NZ211058A patent/NZ211058A/xx unknown
- 1985-02-05 SK SK784-85A patent/SK278084B6/sk unknown
- 1985-02-05 FR FR8501562A patent/FR2559065B1/fr not_active Expired
- 1985-02-05 IT IT8519385A patent/IT1209615B/it active
- 1985-02-06 SE SE8500553D patent/SE8500553L/xx not_active Application Discontinuation
- 1985-02-06 GB GB08503033A patent/GB2153677B/en not_active Expired
- 1985-02-06 SE SE8500553A patent/SE462547B/sv not_active IP Right Cessation
- 1985-02-06 NL NL8500323A patent/NL192780C/nl not_active IP Right Cessation
- 1985-02-06 JP JP60020188A patent/JPS60181017A/ja active Granted
- 1985-02-06 AU AU38488/85A patent/AU577351B2/en not_active Expired
- 1985-02-06 UA UA3848424A patent/UA6028A1/uk unknown
- 1985-02-06 BE BE0/214458A patent/BE901664A/fr not_active IP Right Cessation
- 1985-02-06 PT PT79933A patent/PT79933B/pt unknown
- 1985-02-06 US US06/698,784 patent/US4632828A/en not_active Expired - Lifetime
- 1985-02-06 SU SU853848424A patent/SU1605926A3/ru active
- 1985-02-07 ZA ZA85943A patent/ZA85943B/xx unknown
- 1985-02-07 DK DK057085A patent/DK164149C/da not_active IP Right Cessation
- 1985-02-07 NO NO850477A patent/NO170568C/no not_active IP Right Cessation
- 1985-02-07 HU HU85469A patent/HU194050B/hu unknown
- 1985-02-07 CA CA000473748A patent/CA1240928A/en not_active Expired
- 1985-02-08 KR KR1019850000786A patent/KR930009897B1/ko not_active IP Right Cessation
- 1985-12-31 ES ES550613A patent/ES8703277A1/es not_active Expired
- 1985-12-31 ES ES550614A patent/ES8703278A1/es not_active Expired
-
1990
- 1990-10-03 SG SG803/90A patent/SG80390G/en unknown
- 1990-11-15 HK HK942/90A patent/HK94290A/xx not_active IP Right Cessation
-
1994
- 1994-02-22 BG BG098519A patent/BG60524B2/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2153678B (en) | Pharmaceutical composition | |
| GB8413191D0 (en) | Pharmaceutical composition | |
| GB8426672D0 (en) | Pharmaceutical compositions | |
| GB2165451B (en) | Pharmaceutical compositions | |
| AU4454389A (en) | Pharmaceutical composition | |
| GB8410290D0 (en) | Pharmaceutical compositions | |
| GB8410289D0 (en) | Pharmaceutical compositions | |
| HK94290A (en) | Pharmaceutical composition comprising medroxyprogesterone acetate | |
| GB8513641D0 (en) | Pharmaceutical composition | |
| GB8409961D0 (en) | Pharmaceutical compositions | |
| GB2153676B (en) | Pharmaceutical composition | |
| GB8518565D0 (en) | Pharmaceutical composition | |
| GB8424514D0 (en) | Pharmaceutical composition | |
| GB8421583D0 (en) | Pharmaceutical composition | |
| GB8424510D0 (en) | Pharmaceutical composition | |
| GB8421779D0 (en) | Pharmaceutical composition | |
| GB8424511D0 (en) | Pharmaceutical composition | |
| GB8424167D0 (en) | Pharmaceutical composition | |
| GB8424509D0 (en) | Pharmaceutical composition | |
| GB8429710D0 (en) | Pharmaceutical composition | |
| GB8424512D0 (en) | Pharmaceutical composition | |
| GB8424513D0 (en) | Pharmaceutical composition | |
| GB8426767D0 (en) | Pharmaceutical composition | |
| IE841175L (en) | Pharmaceutical composition | |
| GB8513640D0 (en) | Pharmaceutical composition |